Facebook Pixel “Despite high disease burden, there are no national screening guidelines for multiple myeloma in India” | Bio Spectrum - business - Lisez cet article sur Magzter.com
Passez à l'illimité avec Magzter GOLD

Passez à l'illimité avec Magzter GOLD

Obtenez un accès illimité à plus de 9 000 magazines, journaux et articles Premium pour seulement

$149.99
 
$74.99/Année

Essayer OR - Gratuit

“Despite high disease burden, there are no national screening guidelines for multiple myeloma in India”

Bio Spectrum

|

October 2025

France-headquartered Sebia, a global leader in specialty diagnostics, is continuing its geographic footprint to better serve its customers.

- By Heejin Roh, Vice President – Commercial Operations, Asia Pacific, Sebia, South Korea

Over the decades, the company has earned worldwide recognition for its pioneering expertise in Multiple Myeloma screening, diagnosis, and monitoring, as well as its leadership in hemoglobinopathies diagnosis. In recent years, Sebia has significantly expanded its portfolio in autoimmunity and infectious disease diagnostics through strategic acquisitions – ORGENTEC in 2021 and ZEUS Scientific in 2022. The company is now all set to strengthen its presence in India, thereby expanding its reach, building talent, and raising awareness. Sebia established its presence in India in 2019, and has achieved consistent double-digit growth year after year. To find out more about the company's growth plans in India, BioSpectrum spoke to Heejin Roh, Vice President – Commercial Operations, Asia Pacific, Sebia. Edited excerpts:

Please share details of the new initiatives to be taken to strengthen the company's presence in India.

PLUS D'HISTOIRES DE Bio Spectrum

Bio Spectrum

Biotium's new cell barcoding kit streamlines flow cytometry with single-tube multiplexing

Biotium, a leading provider of fluorescent reagents and kits for life science research, has announced the release of the ViaPlex 2-Color Cell Barcoding Kit.

time to read

1 min

May 2026

Bio Spectrum

Bio Spectrum

NATHEALTH names Dr Sangita Reddy as new President

NATHEALTH, an apex body representing the Indian healthcare industry, has announced Dr Sangita Reddy, Joint Managing Director, Apollo Hospitals Group, as its new President for FY 2026-2027.

time to read

1 min

May 2026

Bio Spectrum

Rs 4.51 Lakh Crore Health Push: How State Budgets Are Powering India's Next Healthcare Leap

In recent years, state health budgets have transformed from simple financial documents into strategic instruments for improving healthcare outcomes.

time to read

7 mins

May 2026

Bio Spectrum

WHO lays focus on simulation exercises to strengthen health emergency readiness

To support countries to prepare more systematically against emergencies, WHO has recently released new global guidance which enables countries to move beyond oneoff emergency drills and establish National Health Simulation Exercise Programmes (NHSEP).

time to read

1 min

May 2026

Bio Spectrum

Bio Spectrum

Akrivia Biosciences decodes breast cancer genomic heterogeneity

Akrivia Biosciences, a cancer genomics startup based in London and Mumbai, has announced a foundational scientific breakthrough that uncovers hidden organisation of cancer genomes, successfully decoding breast cancer genomic heterogeneity, a major bottleneck that has historically hindered the comprehensive understanding of tumour biology in patients.

time to read

1 min

May 2026

Bio Spectrum

Bio Spectrum

Integrating AI for Tech-driven Ayurveda

A promising trend emerging in 2026 is the integration of artificial intelligence (AI) into ayurveda, to not only make ayurveda more accessible and scalable but to also create opportunities to back up ayurveda with science and technology.

time to read

2 mins

May 2026

Bio Spectrum

ASPIRE BIONEST signs MoU with Indian Immunologicals to advance One Health Innovation

ASPIRE BIONEST, a life sciences incubation centre at the University of Hyderabad, has signed a strategic Memorandum of Understanding (MoU) with Indian Immunologicals Ltd. (IIL), a leading vaccine-focused biotechnology company, to advance innovation under the One Health framework.

time to read

1 min

May 2026

Bio Spectrum

MSD India and Smile Foundation award 50 scholarships to aspiring pharmacy students

MSD (known as Merck & Co., Inc., Rahway, N.J., USA in the United States and Canada) in India has announced the awarding of scholarships to 50 students under its corporate social responsibility initiative 'Scholarship for Daughters' programme, a merit-based initiative aimed at supporting young women from underserved communities to pursue a Bachelor of Pharmacy degree at select accredited pharmacy colleges across India.

time to read

1 min

May 2026

Bio Spectrum

Bio Spectrum

Thermo Fisher launches integrated platform to accelerate biologics development

Thermo Fisher Scientific Inc. has announced a next-generation, integrated cell line development platform that enables biologics developers to accelerate time to clinic while maintaining regulatory confidence and commercial scalability.

time to read

1 min

May 2026

Bio Spectrum

Bio Spectrum

Eurofins Viracor unveils ExPECT anti-CD19 (obe-cel) CAR T-cell assay

Eurofins Viracor, a leader in advanced clinical diagnostics, has announced the launch of the ExPECT anti-CD19 (obe-cel) CAR T-cell assay, a cutting-edge solution designed to help clinicians monitor CAR T-cell therapy performance with validated precision and a quick turn-around-time for results.

time to read

1 min

May 2026

Listen

Translate

Share

-
+

Change font size